Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patentsThe following is a sampling of recent Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patent applications (USPTO Patent Application #, Patent Title) sorted by month.
June 2009 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20090159841 - Recovery of optically active epoxy alcohols
20090162358 - Antigen binding proteins
20090162843 - Identification of hpv16 lineage group
20090163475 - Crystalline form of benzazepinium maleate derivative
20090163506 - Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
20090163589 - Calcilytic compounds
20090155283 - Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1
20090155315 - Pharmaceutical product
20090156624 - Methionine aminopeptidase-2 inhibitors and methods of use thereof
20090148434 - Antibody compositions and methods
20090148518 - Pharmaceutical formulations
20090148892 - Novel methods
20090148905 - Antigen-binding constructs
20090149401 - Amide and peptide derivatives of tetraalkylenepentamines as transfection agents
20090149447 - Novel m3 muscarinic acetylcholine receptor antagonists
20090149507 - Method for customized dispensing of variable dose drug combination products for individualizing of therapies
20090149524 - N-(phenylmethyl)-2-(1h-pyrazol-4-yl) acetamide derivatives as p2x7 antagonists for the treatment of pain, inflammation and neurodegeneration
20090142279 - Novel m3 muscarinic acetylcholine receptor antagonists
May 2009 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20090136541 - Immunogenic composition
20090136543 - Vaccine
20090137465 - Novel use
20090137550 - Novel compounds
20090137557 - Calcilytic compounds
20090137568 - Tryclic nitrogen containing compounds and their use as antibacterials
20090130032 - Dental appliance cleanser
20090130145 - Vaccine
20090131431 - Pyrazolo[3,4-b]pyridine compounds, and their use as a pde4 inhibitors
20090131453 - Benzylpiperazine derivatives as motilin receptor antagonists
20090123479 - Immunoglobulins
20090123491 - Novel method for preventing or treating m tuberculosis infection
20090124619 - Novel compounds
20090124629 - 3-(1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors
20090124653 - Muscarinic acetylcholine receptor antagonists
20090125324 - Medical product dispensing systems and methods
20090118313 - Novel compounds
April 2009 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20090111760 - Macrolone compounds
20090104153 - Method of eliciting immune response
20090104153 - Method of eliciting immune response
20090104153 - Method of eliciting immune response
20090104231 - Vaccine
20090104231 - Vaccine
20090104231 - Vaccine
20090105259 - Acyclic 1,4-diamines and uses thereof
20090105259 - Acyclic 1,4-diamines and uses thereof
20090105259 - Acyclic 1,4-diamines and uses thereof
20090093451 - Il-8 receptor antagonists
20090093492 - Il-8 receptor antagonists
20090088374 - Novel use
20090088374 - Novel use
March 2009 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20090081253 - Composition
20090082260 - Combination of an immunosuppressant and a ppar gamma agonist for the treatment of an undesirable immune response
20090082349 - Thiazolones for use as pi3 kinase inhibitors
20090082357 - Prolyl hydroxylase inhibitors
20090074676 - Inhibition of p38 mapk for treatment of obesity
20090075822 - Method of altering the alkaloid composition in poppy plants
20090076061 - Muscarinic acetycholine receptor antagonists
20090069318 - Novel compounds
20090062218 - Macrolone compounds
20090062265 - Pyrrolo-quinoxalinone derivatives as antibacterials
20090062360 - Compounds which inhibit the glycine transporter and uses thereof
February 2009 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20090053687 - Method for the detection of hpv and probes, primers and kits
20090054418 - Antibacterial agents
20090054456 - Benzylpiperazine derivatives and their medical use
20090048252 - Thiazolones for use as pi3 kinase inhibitors
20090038097 - Toothbrush
20090041802 - Immunogenic composition
20090035258 - Methods of treating cancer by administering human il-18 combinations
20090036433 - Heterocyclic compounds, their preparation and their use as antibacterials
20090036461 - Use of azabicyclo hexane derivatives
20090036682 - Quinoline derivatives and their use as 5-ht6 ligands
20090036821 - Iontophoretic transdermal delivery of nicotine salts
January 2009 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20090028828 - Rotavirus vaccine inducing heterotypic cross protection
20090028903 - Novel use
20090030062 - Azabicyclo [3.1.0] hexylphenyl derivatives as modulators of dopamine d3 receptors
20090022755 - Vaccines against chlamydial infection
20090022814 - Cancer treatment method
20090022849 - Prebiotic use of fruits and fruit juices in the promotion of beneficial gut microflora
20090023725 - Fused heteroaryl derivatives for use as p38 kinase inhibitors
20090023742 - Thiazolones for use as pi3 kinase inhibitors
20090023757 - Process for preparing bicyclic compounds
20090013489 - Novel device
20090010970 - Dissolvable tooth whitening strip
20090012011 - Novel compounds
20090012056 - Quinoline compounds capable of binding the cb2 and/or the 5-ht6 receptor
April 2008 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20080093380 - Novel device
20080095777 - Immunogenic composition for use in vaccination against staphylococcei
20080096829 - Macrolone compounds
20080096905 - Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido{4,5-d}pyrimidin-2(1h)-one derivatives
20080096938 - Chemical compounds
20080090773 - Macrolones - amino substituted quinolones
20080090822 - Piperazine derivatives as glyt 1 inhibitors
20080090851 - Bicyclic heteroaromatic compounds
20080090852 - Bicyclic heteroaromatic compounds
20080085289 - Immunogenic composition
March 2008 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20080075658 - Method of radiolabeling formulations for gamma scintigraphy assessment
20080070866 - Chemical compounds
20080063667 - Proder p 1 expressed in a prokaryotic cell
20080064057 - Vaccine protection assay
20080064719 - Crf receptor antagonists and methods relating thereto
20080058279 - Ester-linked gemini surfactant compounds for use in gene therapy
20080058384 - Novel compounds
February 2008 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20080051416 - Novel compounds
20080045532 - Compounds which potentiate ampa receptor and uses thereof in medicine
20080039517 - Pyrrolidinone anilines as progesterone receptor modulators
January 2008 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20080027065 - Compounds
20080020468 - Pharmaceutical analysis apparatus and method
20080021058 - Pyrazolo '3,4-b! pyridine compounds and their use as phosphodiesterase type 4(pde4) inhibitors
20080021073 - Novel heterocyclic compounds
20080014217 - Influenza vaccine
20080014220 - Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52
20080009483 - Antibacterial agents
December 2007 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20070298052 - Drying process for presserving an active agent as a higly viscous liquid
20070292432 - Immunoglobulins
20070293472 - Novel 14 and 15 membered ring compounds
20070293477 - Novel compounds
20070293508 - Crf receptor antagonists and methods relating thereto
20070293511 - Crf receptor antagonists and methods
20070293531 - Muscarinic acetycholine receptor antagonists
20070286861 - Immunoglobulins
20070287701 - Antibacterial agents
20070287705 - Crf receptor antagonists and methods relating thereto
20070280971 - Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
20070281933 - Novel indazole carboxamides and their use
November 2007 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20070271717 - Toothbrush
20070272711 - Squeezable dispensing container
20070273331 - Toothbrush
20070275948 - 7-[4-(4-chlorobenzyloxy)benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipyschotics
20070270417 - Antibacterial agents
20070270432 - Novel method
20070270446 - Reversed pyrimidinone compounds as calcilytics
20070270471 - Compounds which potentiate glutamate receptor and uses thereof in medicine
20070258979 - Chimeric and humanised monoclonal antibodies against interleukin-13
20070259856 - Method for activating trpv4 channel receptors by agonists
20070259951 - Compounds, compositions and methods
20070259965 - Acyclic 1,3-diamine and uses therefor
20070254872 - Antibacterial agents
20070254873 - Chemical compounds
20070254888 - Piperazinediones as oxytocin receptor antagonists
October 2007 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20070249599 - Novel chemical compounds
20070249603 - 3-arylsulfonyl-quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
20070249625 - Il-8 receptor antagonists
20070249642 - Azabicyclo[3.1.0]hex-3-yl}alkyl)pyrimidinedione
20070249672 - Il-8 receptor antagonists
20070243203 - Vaccine for prevention and treatment of hiv-infection
20070244091 - Antibacterial agents
20070244152 - Use of an nk3 antagonist for the treatment of bipolar disorders
20070238751 - Muscarinic acetylcholine receptor antagonists
20070231875 - Apparatus for the disruption of animal cells
20070231876 - Purification process for bacterial cytolysin
20070232599 - Muscarinic acetylcholine receptor antagonists
20070232628 - Calcilytic compounds
September 2007 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20070225276 - 7-phenylsulfonyl-tetrahydro-3-benzazepine dervatives as antipsychotic agents
20070218088 - Dentifrice composition comprising a soluble calcium sequestering agent
20070212328 - Immunogenic compositions
20070212329 - Vaccine compositions comprising an interleukin 18 and saponin adjuvant system
20070213283 - Macrolides substituted at the 4-position
20070213335 - Prolyl hydroxylase inhibitors
20070208031 - Substituted diketopiperazines as oxytocin antagonists
August 2007 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20070203127 - Antibacterial agents
20070203226 - Calcilytic compounds
20070196787 - Method of applying a denture adhesive
20070197603 - Substituted indole ligands for the orl-1 receptor
20070189839 - Fluid dispenser
20070189983 - Tooth whitening composition
20070190059 - Antithrombotic agents
20070191345 - 3-((hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
20070191378 - Anthranilic acid derivatives and their use as activators of the hm74a receptor
20070191457 - Compounds having activity at 5ht2c receptor and uses thereof
20070185088 - M3 muscarinic acetylchoine receptor antagonists
20070185090 - Muscarinic acetylchoine receptor antagonists
20070185117 - Novel 14 and 15 membrered ring compounds
20070185148 - M3 muscarinic acetylchoine receptor antagonists
20070185152 - Inhibitors of akt activity
20070185155 - Muscarinic acetylcholine receptor antagonists
20070185162 - Substituted diketopiperazines as oxytocin receptor antagonists
20070178055 - Dissolvable tooth whitening strip
20070178150 - Pharmaceutical compositions
20070178151 - Spray dried pharmaceutical compositions
20070178156 - Pharmaceutical formulations
20070179131 - Novel m3 muscarinic acetylcholine receptor antagonists
20070179180 - Novel m3 muscarinic acetylcholine receptor antagonists
20070179184 - Novel m3 muscarinic acetylcholine receptor antagonists
20070179192 - Thrombopoietin mimetics
July 2007 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20070172945 - Bioreactor
20070173542 - Peptide deformylase inhibitors
20070173646 - Muscarinic acetylcholine receptor antagonists
20070166777 - Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity
20070167457 - N-aroyl piperazine derivatives as orexin receptor antagonists
20070167485 - Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
20070167494 - Process for preparing a polymorph or rosiglitazone maleate
20070167495 - Pleuromutilin derivatives, process for their preparation and uses thereof
20070160677 - Encapsulation of lipid-based formulations in enteric polymers
20070161627 - Antibacterial agents
20070161638 - Compounds which potentiate glutamate receptor and uses thereof in medicine
20070161673 - P38 kinase inhibitors
20070155819 - Calcilytic compounds
June 2007 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20070149524 - Substituted diketopiperazines and their use as oxytocin antagonists
20070149561 - Azaindole inhibitors of aurora kinases
20070149598 - M3 muscarinic acetylcholine receptor antagonists
20070141146 - Novel compositions
20070141276 - Novel 14 and 15 membered ring compounds
20070142372 - Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis
20070142431 - Quinoline 4-carboxamide derivatives and their use as neurokinin 3 (nk-3) receptor antagonists
20070142438 - Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine d3 receptors
20070142460 - Compounds, compositions and methods
20070142476 - Biphenyl-derivatives as p38 kinase inhibitors
20070134326 - Composition for releasing a weak base for an extended period of time
20070135456 - Medicaments with hm74a receptor activity
20070135478 - Muscarnic acetylchorine receptor antagonists
20070129338 - Thrombopoietin mimetics
20070129354 - Biphenyl carboxylic amide p38 kinase inhibitors
20070129382 - Crf receptor antagonists, their preparations, their pharmaceutical composition, and their uses
20070129396 - Muscarinic acetylcholine receptor antagonists
May 2007 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20070119868 - Pumping and floating pistons coated with a barrier layer
20070123548 - Pth agonists
20070123561 - Preparation of 1,7-disubstituted azabensimidazoles as kinase inhibitors
20070116711 - Pertussis antigens and use thereof in vaccination
20070116714 - Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
20070117090 - Processing nucleic acid
20070117818 - Pyrimidinone compounds useful as kinase inhibitors
20070117820 - Heterocyclic urea derivatives for the treatment of pain
20070117832 - Novel compound, corresponding compositons, preparation and/or treatment methods
20070111995 - Pyrazolo [3,4-b] pyridine compounds and their use as phosphodiesterase inhibitors
20070105824 - Methods for treating degenerative diseases/injuries
20070105850 - Biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors
20070105895 - Muscarinic acetycholine receptor antagonists
20070099940 - Pth agonists
April 2007 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20070090133 - Actuator cap for aerosol
20070093473 - 7-heteroarylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
20070086967 - Treatment of psoriasis with rosiglitazone
20070086975 - Polymeric micellar complexes and drug delivery vehicles thereof
20070077641 - Methionine aminopeptidase and methods of use
March 2007 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20070048261 - Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases
February 2007 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20070042047 - Vaccines
20070042977 - Vaccine
20070043026 - Dopamine receptor modulators as antipsychotic agents
20070037717 - Denture adhesive solvent compositions
20070037757 - Compounds
20070031449 - Vaccine
20070032504 - Polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline
20070026010 - Purification process for bacterial cytolysin
20070027139 - Piperazinyl-quinoline derivatives useful for the treatment of cns disorders
January 2007 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20070021429 - Condensed n-heterocyclic compounds and their use as crf receptor antagonists
20070015721 - Hiv-gag codon-optimised dna vaccines
20070015766 - Quinoline derivatives as nk-3 and nk-2 antagonists
20070006410 - Toothbrush
20070010534 - Novel compounds
20070004708 - Condensed n-heterocyclic compounds and their use as crf receptor antagonists
20070004710 - Antibacterial agents
20070004771 - Preparation of 1,6,7-trisubstituted azabenzimidazoles as kinase inhibitors
December 2006 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20060293338 - Novel chemical compounds
20060293348 - Novel compounds
20060293353 - Matrix metalloproteinase inhibitors
20060287334 - Quinoline compounds and pharmeceutical compositions containing them
20060287346 - Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer
20060281757 - Phenyl sulfone derivatives and their use in the treatment of cns disorders
20060281786 - Compounds having activity at 5ht2c receptor and uses thereof
20060276447 - Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain
20060276503 - Novel process salts compositions and use
20060276516 - Nicotinamide derivatives useful as p38 inhibitors
November 2006 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20060266431 - Device for introducing a liquid into a pharmaceutical container
20060264429 - Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
20060264479 - Nicotinamide derivatives useful as p38 inhibitors
20060248667 - Brush part for electric toothbrush
20060251676 - Hpv-16 and-18 l1 vlp vaccine
20060252769 - Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor
20060252790 - Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
20060246060 - Novel stable formulation
20060246090 - Vaccine against hcv
20060247233 - Thiazoles inhibitors of the alk-5 receptor
20060247271 - Sulphonyl hydroxamic acid derivatives as inhibitors of s-cd23
20060247280 - Compounds and methods
October 2006 - Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 patents
20060236482 - Toothbrush
20060240045 - Neisserial vaccine compositions comprising a combination of antigens
20060241126 - Pyrimidinone derivatives and their use in the treatment of atherosclerosis
20060241149 - Chemical compounds
20060241179 - Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
20060233839 - Novel compounds
20060234327 - Methods for identifying enzyme inhibitors and protein kinases
20060235074 - Matrix metalloproteinase inhibitors
20060229312 - Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
20060229315 - 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
20060229341 - Peptide deformylase inhibitors
20060222694 - Stabilized topotecan liposomal composition and methods
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Smithkline Beecham Corporation Corporate Intellectual Property-us, Uw2220 with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
